Role of aging versus the loss of estrogens in the reduction in vascular function in female rats

Endocrinology

Volumn 150, Issue 1, 2009, Pages 212-219

  Stice, James P ^a   Eiserich, Jason P ^a   Knowlton, A A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ESTROGEN; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

AGED; AGING; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR FIBROSIS; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASODILATATION;

AGING; ANIMALS; AORTA; BLOOD VESSELS; ESTROGENS; FEMALE; ISOMETRIC CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OVARIECTOMY; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED BN; RNA; VASOCONSTRICTION; VASODILATION;

EID: 58149465733     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0640     Document Type: Article

References (43)

1. Stevenson JC 2000 Cardiovascular effects of oestrogens. J Steroid Biochem Mol Biol 74:387-393
2. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD 2002 Postmeno-pausal hormone replacement therapy: scientific review. JAMA 288:872-881
3. Turgeon JL, McDonnell DP, Martin KA, Wise PM 2004 Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304: 1269-1273
4. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA
5. [Erratum (2008) 299:1426] 297:1465-1477
6. Ferrari AU, Radaelli A, Centola M 2003 Invited review: aging and the cardiovascular system. J Appl Physiol 95:2591-2597
7. Taddei S, Virdis A, Mattel P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Salvetti A 1995 Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91:1981-1987
8. Chou TC, Yen MH, Li CY, Ding YA 1998 Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31:643-648
9. Ruetten H, Zabel U, Linz W, Schmidt HH 1999 Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85:534-541
10. Kloss S, Bouloumie A, Mulsch A 2000 Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35(1 Pt 1):43-47
11. Lin CS, Liu X, Tu R, Chow S, Lue TF 2001 Age-related decrease of protein kinase G activation in vascular smooth muscle cells. Biochem Biophys Res Commun 287:244-248
12. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
13. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR 2000 Membrane estrogen receptor engagement activates 219 endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87:677-682
14. Guo X, Lu X, Ren H, Levin ER, Kassab GS 2006 Estrogen modulates the mechanical homeostasis of mouse arterial vessels through nitric oxide. Am J Physiol Heart Circ Physiol 290:H17SS-H1797
15. Sarrel PM 1999 The differential effects of oestrogens and progestins on vascular tone. Hum Reprod Update 5:205-209
16. White RE 2002 Estrogen and vascular function. Vascul Pharmacol 38:73-80
17. Voss MR, Stallone JN, Li M, Cornelussen RN, Knuefermann P, Knowlton AA 2003 Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 285:H687-H692
18. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA 2002 Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296:2391-2394
19. Van Der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE 2000 Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 279:L537-L546
20. Voss MR, Gupta S, Stice JP, Baumgarten G, Lu L, Tristan JM, Knowlton AA 2005 Effect of mutation of amino acids 246-251 (KRKHKK) in HSP72 on protein synthesis and recovery from hypoxic injury. Am J Physiol Heart Circ Physiol 289:H2519-H2525
21. Chomczynski P, Sacchi N 2006 The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1:581-585
22. Greiner DZ, Personius BE, Andrews TC 1999 Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease. Am J Cardiol 83:247-249
23. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, Ohama K, Chayama K, Oshima T 2001 Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 37:651-657
24. Arenas IA, Armstrong SJ, Xu Y, Davidge ST 2006 Tumor necrosis factor-a and vascular angiotensin II in estrogen-deficient rats. Hypertension 48:497-503
25. Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, Ahlbory K, Rosen R, Bohm M, Nickenig G 2001 Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103:435-441
26. Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, Mu W, Oyekan AO, Johnson RJ 2005 Loss of nitric oxide and endothelial-derived hyperpolarizmg factor-mediated responses in aging. Kidney Int 68: 2154-2163
27. Soucy KG, Ryoo S, Benjo A, Lim HK, Gupta G, Sohi JS, Elser J, Aon MA, Nyhan D, Shoukas AA, Berkowitz DE 2006 Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. J Appl Physiol 101:1751-1759
28. Jacobson A, Yan C, Gao Q, Rincon-Skinner T, Rivera A, Edwards J, Huang A, Kaley G, Sun D 2007 Aging enhances pressure-induced arterial superoxide formation. Am J Physiol Heart Circ Physiol 293:H1344-H1350
29. White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, Nyhan D, Shoukas AA, Hare JM, Berkowitz DE 2006 Knockdown of arginasel restores NO signaling in the vasculature of old rats. Hypertension 47:245-251
30. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler S 2001 Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89:709-715
31. Hamilton KL, Lin L, Wang Y, Knowlton AA 2008 Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics 32:254-263
32. Chen L, Daum G, Fischer JW, Hawkins S, Bochaton-Piallat ML, Gabbiani G, Clowes AW 2000 Loss of expression of the β subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats. Circ Res 86:520-525
33. Krumenacker JS, Hyder SM, Murad F 2001 Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. Proc Natl Acad Sci USA 98:717-722
34. Cabilla JP, Diaz Mdel C, Machiavelli LI, Poliandri AH, Quinteros FA, Lasaga M, Duvilanski BH 2006 17β-Estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland. Endocrinology 147:4311-4318
35. Friebe A, Koesling D 2003 Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 93:96-105
36. Keller ET, Zhang J, Yao Z, Qi Y 2001 The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Ma-caca mulatta) model of menopause. J Reprod Immunol 50:41-55
37. Zegura B, Keber I, Sebestjen M, Koenig W 2003 Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. Atherosclerosis 168:123-129
38. Marro ML, Peiro C, Panayiotou CM, Baliga RS, Meurer S, Schmidt HH, Hobbs AJ 2008 Characterization of the human al 31 soluble guanylyl cyclase promoter: key role for NF-kB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor. J Biol Chem 283:20027-20036
39. Vazquez-Padron RI, Pham SM, Pang M, Li S, Aitouche A 2004 Molecular dissection of mouse soluble guanylyl cyclase al promoter. Biochem Biophys Res Commun 314:208-214
40. Lakatta EG 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 107:490-497
41. Qiu H, Depre C, Ghosh K, Resuello RG, Natividad FF, Rossi F, Peppas A, Shen YT, Vatner DE, Vainer SF 2007 Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates. Circulation 116:669-676
42. Wolin MS 2005 Loss of vascular regulation by soluble guanylate cyclase is emerging as a key target of the hypertensive disease process. Hypertension 45:1068-1069
43. Boerrigter G, Burnett Jr JC 2007 Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease. Car-diovasc Drug Rev 25:30-45